Imipenem/cilastatin sodium in the treatment of obstetric and gynecologic infections
Doko, F.
Japanese Journal of Antibiotics 39(5): 1427-1431
1986
ISSN/ISBN: 0368-2781 PMID: 3463788 Document Number: 268568
Imipenem/cilastatin sodium (MK-0787/MK-0791), a carbapenem antibiotic and a dehydropeptidase-I inhibitor, was administered at a dose of 500 mg/500 mg twice a day for 5 days for the treatment of obstetric and gynecologic infections. A total of 10 patients was evaluated, and the clinical results were rated as excellent in 1, good in 7 and poor in 2 patients. As a side effect, rash was observed in 1 patient but it disappeared by the third day after the treatment was discontinued. No abnormal laboratory findings were observed in our study.
Document emailed within 1 workday
Related Documents
Fujii, R.; Sakata, H.; Inyaku, F.; Fujita, K.; Maruyama, S.; Yoshioka, H.; Hashira, S.; Tajima, T.; Nakazawa, S.; Sato, H. 1989: Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group Japanese Journal of Antibiotics 42(4): 953-972Oizumi, K.; Rikimaru, T.; Shiraishi, T.; Motohiro, A.; Yoshida, M.; Watanabe, K.; Maruyama, R.; Ishibashi, T.; Kitahara, Y.; Kido, M.; Yoshii, C.; Hara, N.; Ikeda, A.; Yamada, H.; Ninomiya, K.; Matsuzaki, Y.; Ichinose, Y.; Namba, K.; Kodama, T.; Kunitake, R.; Miyazaki, N.; Abe, K.; Matsunaga, R.; Ide, H.; Kamae, I. 1999: Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure Japanese Journal of Antibiotics 52(1): 1-15
Oizumi, K.; Rikimaru, T.; Shiraishi, T.; Motohiro, A.; Yoshida, M.; Watanabe, K.; Maruyama, R.; Ishibashi, T.; Kitahara, Y.; Kido, M.; Yoshii, C.; Hara, N.; Ikeda, A.; Yamada, H.; Ninomiya, K.; Matsuzaki, Y.; Ichinose, Y.; Namba, K.; Kodama, T.; Kunitake, R.; Miyazaki, N.; Abe, K.; Matsunaga, R.; Ide, H.; Kamae, I. 1999: Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure Japanese Journal of Antibiotics 52(1): 1-15
Konaga, E.; Takeuchi, H.; Orita, K.; Fuchimoto, S.; Ogawa, K.; Kitagawa, T.; Tokuda, N.; Kimura, H.; Hamada, F.; Nishiyama, Y. 1991: Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections Japanese Journal of Antibiotics 44(12): 1341-1350
Takamoto, M.; Ishibashi, T.; Toyoshima, H.; Tanaka, H.; Tamaru, N.; Watanabe, K.; Yoshida, M.; Tokunaga, N.; Ichikawa, Y.; Oizumi, K. 1994: Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections Japanese Journal of Antibiotics 47(9): 1131-1144
Mikasa, K.; Sawaki, M.; Konishi, M.; Narita, N. 1990: Clinical efficacy of imipenem/cilastatin sodium in patients with respiratory tract infections caused by Pseudomonas aeruginosa Japanese Journal of Antibiotics 43(1): 9-13
Mao, P.; Enrichens, F.; Olivero, G.; Sciascia, C.; Benedetto, G.; Franchello, A.; Olivero, S. 1991: Imipenem-cilastatin in the treatment of hospital infections Journal of ChemoTherapy 3(Suppl 1): 205-207
Leaper, D.; Thomas, W.; Kennedy, R.; Leow, C.; Avery, D. 1987: Treatment of intra-abdominal infections using imipenem/cilastatin Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 467-468
Oomomo, Y.; Maruhashi, T.; Hanaoka, J.; Minagawa, Y.; Yuzawa, H.; Tokunaga, A.; Takahashi, T.; Sasagawa, S.; Takeuchi, S. 1986: Clinical studies on the effect of imipenem/cilastatin sodium on infections in obstetrics and gynecology. Tissue concentrations and clinical effects Japanese Journal of Antibiotics 39(5): 1342-1349
Hou, F.; Li, J.; Wu, G.; Zheng, B.; Chen, Y.; Gu, J.; Wang, H.; Huo, L.; Xue, X.; Jia, C.; Yin, Y.; Tian, X.; Ren, S. 2002: A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections Chinese Medical Journal 115(12): 1849-1854
Iwai, N.; Miyazu, M.; Shibata, M.; Nakamura, H.; Katayama, M.; Taneda, Y.; Inokuma, K. 1986: Studies on imipenem/cilastatin sodium in the field of pediatrics Japanese Journal of Antibiotics 39(7): 1847-1865
Chimura, T.; Morisaki, N.; Hirayama, T.; Matsuo, M. 1988: Clinical studies on imipenem/cilastatin sodium in perinatal use Japanese Journal of Antibiotics 41(11): 1751-1757
Nagata, K.; Yokoyama, M.; Ohnishi, A.; Izumi, Y. 1986: Clinical studies on imipenem/cilastatin sodium in pediatric field Japanese Journal of Antibiotics 39(7): 1708-1714
Matsuda, S.; Suzuki, M.; Oh, K. 1988: Clinical studies on imipenem/cilastatin sodium in the perinatal period Japanese Journal of Antibiotics 41(11): 1774-1777
Motohiro, T.; Koga, T.; Shimada, Y.; Tomita, S.; Fujimoto, T.; Nishiyama, T.; Tominaga, K.; Yamashita, F.; Suzuki, K.; Toyoda, O. 1986: Pharmacokinetic and clinical studies of imipenem/cilastatin sodium in the pediatric field Japanese Journal of Antibiotics 39(7): 1889-1911
Chimura, T.; Morisaki, N.; Matsuo, M. 1986: Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology Japanese Journal of Antibiotics 39(6): 1519-1525
Nakashima, T.; Nakashima, S.; Hayakawa, F.; Miyachi, Y.; Hakamada, S.; Kuno, K. 1986: Fundamental and clinical studies on imipenem/cilastatin sodium in the field of pediatrics Japanese Journal of Antibiotics 39(7): 1828-1846
Naito, H.; Hara, T.; Akagi, T.; Masaoka, T.; Kudo, Y.; Iwasaki, K.; Matsuo, M.; Urabe, T.; Fujiwara, A. 1986: Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology Japanese Journal of Antibiotics 39(5): 1401-1411
Matsuda, S.; Oh, K.; Tateno, M.; Kojima, Y.; Hirabayashi, K.; Okada, E.; Doko, F.; Kawai, J. 1991: Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology Japanese Journal of Antibiotics 44(12): 1359-1367
Nakazawa, S.; Sato, H.; Narita, A.; Matsumoto, K.; Suzuki, H.; Nakazawa, S.; Chikaoka, H.; Koido, R.; Kamigaki, M.; Nakada, Y. 1986: Fundamental and clinical studies with imipenem/cilastatin sodium, a new carbapenem antibiotic, in the field of pediatrics Japanese Journal of Antibiotics 39(7): 1745-1764